IMCC

IM Cannabis Corp.
CAPPED RATING

IM Cannabis Corp. (IMCC) is rated D+ (1.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (F). The rating has held at D+ for 9 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
1.7 / 5.0
D+
Value
B-
Factor Score 3.0 / 5.0
Growth
D-
Factor Score 0.9 / 5.0
Profitability
D+
Factor Score 1.5 / 5.0
Momentum
F
Factor Score 0.3 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -0.4
EV / EBITDA -1.5
Rev Growth YoY -40.2%
Gross Margin 12.5%
Price Return 3M -85.3%
Price Return 12M -98.7%
Catalyst Signal 0.00
Market Cap $947.3K
TTM Revenue $45.8M
Price / Sales 0.0
ROE N/A

Historical Factor Score Progression

Held D+ for 9 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 B- (3.0) D- (0.9) D+ (1.5) F (0.3) C+ (2.6) D+ (1.7)
2026-11-05 B- (3.0) D- (0.8) D+ (1.5) F (0.4) C+ (2.7) D+ (1.7)
2026-10-29 B- (3.0) D- (0.8) D+ (1.6) F (0.5) C+ (2.7) D+ (1.7)
2026-10-22 B- (3.0) D- (0.8) D+ (1.6) F (0.5) C+ (2.6) D+ (1.7)
2026-10-15 B- (3.0) D- (0.8) D+ (1.6) F (0.5) C+ (2.6) D+ (1.7)
Page 1 of 4